UT Health Science Center-San Antonio: Molecule Shows Potential to Combat Treatment Resistance in Brain Tumor Glioblastoma
May 18, 2023
May 18, 2023
SAN ANTONIO, Texas, May 18 (TNSjou) -- The University of Texas Health Science Center at San Antonio issued the following news release:
* * *
Glioblastoma-impacted mice lived longer when treated with combination of molecule drug and chemotherapy agent
* * *
Glioblastoma (GBM), a highly devastating brain tumor, has long posed challenges as effective treatments have remained elusive. Despite responding initially to treatment, GBM patients often ex . . .
* * *
Glioblastoma-impacted mice lived longer when treated with combination of molecule drug and chemotherapy agent
* * *
Glioblastoma (GBM), a highly devastating brain tumor, has long posed challenges as effective treatments have remained elusive. Despite responding initially to treatment, GBM patients often ex . . .